Learn more

FARMAK

Overview
  • Total Patents
    22
About

FARMAK has a total of 22 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Czechia. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are SHANGHAI DESANO PHARMACEUTICAL, ASH STEVENS INC and SHANGHAI DESANO PHARMACEUTICALS INVEST CO LTD.

Patent filings in countries

World map showing FARMAKs patent filings in countries
# Country Total Patents
#1 Czechia 22

Patent filings per year

Chart showing FARMAKs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Grepl Martin 10
#2 Hradil Pavel 10
#3 Slezar Petr Ing 7
#4 Grepl Martin Ing 7
#5 Hradil Pavel Doc Ing Csc 7
#6 Eluzar Petr 6
#7 Kvapil Lubomir Rndr 6
#8 Oremus Vladimir 5
#9 Koristek Kamil 4
#10 Simunkova Petra Mgr 4

Latest patents

Publication Filing date Title
CZ2013320A3 Polymorph E, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine and process for its preparation
CZ2011517A3 Process for preparing 2-[4-[(methylamino)carbonyl]-1-H-pyrazol-1-yl]adenosine monohydrate
CZ2011512A3 Process for preparing (1R,2S,3R,4S)-N-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl]-1-cyclohexylmethyl[2,3-bicyclo[2.2.1]heptanedicarboxamide hydrochloride
CZ302818B6 Purification process of bicyclic dicarboxylic acid imides
CZ2010714A3 Process for preparing extreme optically pure 2-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione
CZ2009819A3 Process for preparing and processing 6-(trifluoromethoxy)-2-benzothiazolamine (riluzole) with minumum of subsidiary products
CZ301776B6 Process for preparing 2-amino-3-benzoylphenylacetamide (nepafenac) with minimum by-products
CZ301145B6 Process for preparing N-(1-benzo[b]thien-2-ylethyl)-N-hydroxyurea
CZ200849A3 Process for preparing 4-[3,5-bis(2-hydroxyphenyl)-[1, 2, 4]triazol-1-yl]-benzoic acid
CZ2006434A3 Process for preparing salts of 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol (quetiapine) and purification process of such salts
CZ2006102A3 Process for preparing 1-benzyl-4-(5,6-dimethoxyindan-1-on-2-yl)methylpiperidine (donepezil free base) of high purity
CZ20041027A3 Process for preparing sulfoxide of benzimidazole type of extreme purity having generic name Rabeprazol
CZ2004967A3 Purification process of 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol
CZ2004384A3 Process for preparing 2-[2-(4-dibenzo [b,f][1,4] thiazepin-11-yl-1-piperazinyl)-ethoxy]ethanol
CZ2004218A3 Process for preparing 4-chloro-N-(4,5-dihydro-1-H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine
CZ20031204A3 Process for preparing racemic 3- phenyl-3-(2-methoxy-5-methyl phenyl)propionic acid
CZ2003682A3 Process for preparing N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl acetamide
CZ2003111A3 Enantioselective reduction process of 5-[3-aza-5-(2-ethoxyphenoxy)-2-methylpent-2-enyl]-2-methoxybenzenesulfonamide using chiral acyloxyborohydrides
CZ20012077A3 Process for preparing R- and S-isomers of 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
CZ20002952A3 Process for preparing 6-(5-chloropyrid-2-yl)-5-hydroxy-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine